AG˹ٷ

STOCK TITAN

Privia Health Reports First Quarter 2025 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Privia Health (NASDAQ: PRVA) reported strong Q1 2025 financial results with significant growth across key metrics. Total revenue increased 15.6% to $480.1M, while operating income surged 534% to $5.2M. The company saw net income grow 41.4% to $4.2M. Key operational metrics showed robust performance with Practice Collections up 12.8% to $798.6M and Adjusted EBITDA rising 35.1% to $26.9M. Privia expanded into Arizona through a $95M acquisition of Integrated Medical Services, adding approximately 70 healthcare providers. The company raised its FY2025 guidance to the mid-to-high end of most metrics, maintaining strong growth momentum while expecting minimal increase in value-based shared savings accruals.

Privia Health (NASDAQ: PRVA) ha riportato solidi risultati finanziari nel primo trimestre 2025 con una crescita significativa nei principali indicatori. I ricavi totali sono aumentati del 15,6% raggiungendo 480,1 milioni di dollari, mentre l'utile operativo è cresciuto del 534% arrivando a 5,2 milioni di dollari. L'azienda ha registrato un utile netto in aumento del 41,4%, pari a 4,2 milioni di dollari. I principali indicatori operativi hanno mostrato una performance robusta con le collezioni delle pratiche in crescita del 12,8% a 798,6 milioni di dollari e l'EBITDA rettificato salito del 35,1% a 26,9 milioni di dollari. Privia si è espansa in Arizona attraverso un'acquisizione da 95 milioni di dollari di Integrated Medical Services, aggiungendo circa 70 operatori sanitari. L'azienda ha rivisto al rialzo le previsioni per l'anno fiscale 2025 verso la fascia medio-alta della maggior parte degli indicatori, mantenendo un forte slancio di crescita e prevedendo un aumento minimo degli accantonamenti per risparmi condivisi basati sul valore.
Privia Health (NASDAQ: PRVA) reportó sólidos resultados financieros en el primer trimestre de 2025 con un crecimiento significativo en métricas clave. Los ingresos totales aumentaron un 15,6% hasta 480,1 millones de dólares, mientras que el ingreso operativo se disparó un 534% hasta 5,2 millones de dólares. La compañía registró un crecimiento del ingreso neto del 41,4%, alcanzando los 4,2 millones de dólares. Las métricas operativas clave mostraron un rendimiento sólido con las cobranzas de prácticas aumentando un 12,8% a 798,6 millones de dólares y el EBITDA ajustado subiendo un 35,1% hasta 26,9 millones de dólares. Privia se expandió a Arizona mediante una adquisición de 95 millones de dólares de Integrated Medical Services, sumando aproximadamente 70 proveedores de salud. La empresa elevó sus previsiones para el año fiscal 2025 hacia el rango medio-alto de la mayoría de las métricas, manteniendo un fuerte impulso de crecimiento y esperando un aumento mínimo en los acumulados de ahorros compartidos basados en el valor.
Privia Health(NASDAQ: PRVA)� 2025� 1분기� 주요 지� 전반� 걸쳐 상당� 성장� 기록하며 강력� 재무 실적� 발표했습니다. � 매출은 15.6% 증가� 4� 8,010� 달러� 기록했고, 영업이익은 534% 급증하여 520� 달러� 달했습니�. 순이익은 41.4% 증가� 420� 달러� 기록했습니다. 주요 운영 지표도 견조� 성과� 보이� 실무 수금액은 12.8% 증가� 7� 9,860� 달러, 조정 EBITDA� 35.1% 상승� 2,690� 달러� 기록했습니다. Privia� 9,500� 달러 규모� Integrated Medical Services 인수� 통해 애리조나 주로 사업� 확장했으�, � 70명의 의료 제공자를 추가했습니다. 회사� 2025 회계연도 가이던스를 대부� 지표의 중상� 범위� 상향 조정하며 강한 성장 모멘텀� 유지하고, 가� 기반 공유 절감 누적액은 최소한으� 증가� 것으� 예상했습니다.
Privia Health (NASDAQ : PRVA) a publié de solides résultats financiers pour le premier trimestre 2025, avec une croissance significative sur les principaux indicateurs. Le chiffre d'affaires total a augmenté de 15,6 % pour atteindre 480,1 millions de dollars, tandis que le résultat d'exploitation a bondi de 534 % pour s'établir à 5,2 millions de dollars. La société a enregistré une croissance du bénéfice net de 41,4 %, atteignant 4,2 millions de dollars. Les indicateurs opérationnels clés ont montré une performance robuste avec les encaissements des pratiques en hausse de 12,8 % à 798,6 millions de dollars et l'EBITDA ajusté en progression de 35,1 % à 26,9 millions de dollars. Privia s'est développée en Arizona grâce à une acquisition de 95 millions de dollars d'Integrated Medical Services, ajoutant environ 70 prestataires de soins de santé. La société a relevé ses prévisions pour l'exercice 2025 vers le milieu à la haute gamme de la plupart des indicateurs, maintenant une forte dynamique de croissance tout en prévoyant une augmentation minimale des provisions pour économies partagées basées sur la valeur.
Privia Health (NASDAQ: PRVA) meldete starke Finanzergebnisse für das erste Quartal 2025 mit erheblichem Wachstum bei wichtigen Kennzahlen. Der Gesamtumsatz stieg um 15,6 % auf 480,1 Mio. USD, während das Betriebsergebnis um 534 % auf 5,2 Mio. USD zunahm. Das Unternehmen verzeichnete ein Nettoeinkommen, das um 41,4 % auf 4,2 Mio. USD wuchs. Wichtige operative Kennzahlen zeigten eine robuste Leistung mit Praxis-Einnahmen, die um 12,8 % auf 798,6 Mio. USD stiegen, und bereinigtem EBITDA, das um 35,1 % auf 26,9 Mio. USD anstieg. Privia expandierte nach Arizona durch den Erwerb von Integrated Medical Services für 95 Mio. USD und fügte etwa 70 Gesundheitsdienstleister hinzu. Das Unternehmen hob seine Prognose für das Geschäftsjahr 2025 auf den mittleren bis oberen Bereich der meisten Kennzahlen an, behielt dabei ein starkes Wachstumstempo bei und erwartet nur einen minimalen Anstieg bei den wertbasierten gemeinsamen Einsparungsrückstellungen.
Positive
  • Revenue growth of 15.6% YoY to $480.1M
  • Operating income increased 534% to $5.2M
  • Practice Collections grew 12.8% to $798.6M
  • Adjusted EBITDA up 35.1% to $26.9M
  • Strategic expansion into Arizona market through $95M acquisition
  • Raised FY2025 guidance to mid-to-high end of ranges
  • Expected 80% conversion of Adjusted EBITDA to free cash flow
Negative
  • Minimal expected increase in value-based shared savings accruals
  • Stock compensation expense increased to $17.8M from $11.9M YoY

Insights

Privia Health reports strong Q1 with 15.6% revenue growth, enters Arizona market, and raises 2025 guidance, demonstrating operational momentum and successful expansion.

Privia Health delivered impressive Q1 2025 results, with revenue climbing 15.6% to $480.1 million and operating income surging 534% to $5.2 million. Net income rose 41.4% to $4.2 million ($0.03 per share), while non-GAAP adjusted net income increased 23.3% to $27.8 million ($0.22 per share).

The performance reflects Privia's success in both expanding its provider network and driving same-store growth. Implemented providers grew 11.7% to 4,871, while value-based care attributed lives increased 11.1% to 1.27 million. These operational metrics directly translated to financial results, with Practice Collections (the total revenue collected by all practices on the Privia platform) rising 12.8% to $798.6 million.

Notably, Adjusted EBITDA showed outsized growth of 35.1% to $26.9 million, demonstrating improved profitability as the company scales. Management expects at least 80% of Adjusted EBITDA to convert to free cash flow in 2025, highlighting the capital efficiency of Privia's physician enablement model.

The company's expansion into Arizona through the $95 million acquisition of Integrated Medical Services (IMS) represents significant geographic growth. IMS brings approximately 70 physicians and advanced practice providers across 21 locations and manages over 28,000 patient lives in value-based care arrangements. This acquisition is expected to be profitable starting in Q4 2025, serving as the anchor practice for Privia Medical Group—Arizona.

Management has raised its full-year 2025 guidance to the mid-to-high end of previously provided ranges for most metrics. This increased confidence comes despite conservative assumptions about value-based shared savings accruals, suggesting potential upside if value-based care performance exceeds expectations.

The strong quarterly execution across operational and financial metrics, combined with successful market expansion and raised guidance, indicates robust momentum for Privia's physician enablement platform and value-based care strategy.

  • Strong First Quarter Performance and Operating Execution
  • Enters the State of Arizona
  • Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged

ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March31, 2025.

Three Months Ended March 31,
($ in millions, except per share amounts)20252024Change (%)*
Total revenue$480.1$415.215.6%
Gross profit$103.6$93.411.0%
Operating income$5.2$0.8534.0%
Net incomea$4.2$3.041.4%
Non-GAAP adjusted net incomeb d e$27.8$22.523.3%
Net income per share$0.03$0.0250.0%
Non-GAAP adjusted net income per shareb d e$0.22$0.1822.2%
* Any slight variations in totals are due to rounding.

a. Net income for the three months ended March31, 2025, included $17.8 million in non-cash stock compensation expense. Net income for the three months ended March31, 2024 included $11.9 million in non-cash stock compensation expense.

b. Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.

First Quarter 2025 highlights include:

  • Continued strength in same-store growth and new provider additions;
  • Practice Collections of $798.6M, +12.8% versus 1Q�24; and
  • Adjusted EBITDA b d e of $26.9M, +35.1% versus 1Q�24.

Key Operating and Non-GAAP Financial Metrics b, d, e

Three Months Ended March 31,
($ in millions)20252024Change (%)
Implemented Providers4,8714,35911.7%
Value-Based Care Attributed Lives1,270,0001,143,00011.1%
Practice Collections$798.6$707.712.8%
Care Marginb d$105.3$94.910.9%
Platform Contributionb d$51.7$44.715.6%
Adjusted EBITDAb d e$26.9$19.935.1%

Privia Health Enters the State of Arizona

On April 9, 2025, Privia Health announced its entrance into the state of Arizona in partnership with Integrated Medical Services (IMS), one of the largest independent multi-specialty practices in the state. IMS has approximately 70 physicians and advanced practice providers in 21 locations, and manages over 28,000 patient lives in value-based care arrangements across Commercial, Medicare, MA and Medicaid programs. Privia Health paid $95 million in cash at closing.

IMS is the anchor practice in the launch of Privia Medical Group—Arizona, and is expected to be implemented on the Privia Platform in the fourth quarter of 2025. The transaction and launch in Arizona is expected to be profitable starting in the fourth quarter of 2025.

Updated FY�25 Guidance c d e f

Privia Health raised its full-year 2025 outlook to the mid- to high end of most of its guidance ranges, as follows:

FY 2024Initial FY 2025 Guidance at 2.27.25cUpdated FY 2025 Guidance at 5.8.25
($ in millions)ActualLowHigh
Implemented Providers4,7895,2005,300Mid to High End
Attributed Lives1,256,0001,300,0001,400,000Unchanged
Practice Collections$2,968.0$3,150$3,250Mid to High End
GAAP Revenue$1,736.4$1,800$1,900Mid to High End
Care Marginc d$403.9$435$445Mid to High End
Platform Contributionc d$195.6$208$218Mid to High End
Adjusted EBITDAc d e$90.5$105$110Mid to High End
  • Guidance assumes minimal year-over-year increase in value-based shared savings accruals given current environment
  • Guidance includes impact of Arizona market entry, and assumes no other new business development activity
  • De minimis capital expenditures expected in full-year 2025
  • At least 80% of Adjusted EBITDA expected to convert to free cash flow in full-year 2025
  • Effective tax rate expected to be approximately 26-28%
c.Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of gross margin, operating income and net income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons, management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures.
d.See “Key Metrics and Non-GAAP Financial Measures� for more information as to how the Company defines and calculates Implemented Providers, Attributed Lives, Practice Collections, Care Margin, Platform Contribution, and Adjusted EBITDA, and for a reconciliation of the most comparable GAAP measures to Care Margin, Platform Contribution, Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income Per Share.
e.Certain non-recurring or non-cash and other expenses will be treated as an add back in the reconciliation of Net Income to Adjusted EBITDA, and the reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share, the details of which can be found in the Reconciliation schedules near the end of this and in future quarterly press releases.
f.Any slight variations in totals due to rounding.

Webcast and Conference Call Information

The Company will host a conference call on May8, 2025, at 8:00 am ET to discuss these results and management’s outlook for future financial and operational performance. You can visit to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. If you wish to participate in the live conference call, then please go to to pre-register and obtain your dial-in number and passcode.

This news release and the financial statements contained herein, and the slide presentation for the webcast, are also available on the Privia Health Investor Relations website at .

About Privia Health

Privia Health� is one of the largest physician enablement companies in the United States with a presence in 15 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,200+ physician practices, improve the patient experience for 5.2+ million patients, and reward 4,800+ physicians and advanced practitioners for delivering high-value care.

Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit and connect with us on .

Non-GAAP Financial Measures

The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States ("GAAP"). From time to time, in press releases, financial presentations, earnings conference calls or otherwise, the Company may disclose certain non-GAAP financial measures. The non-GAAP financial measures presented in this press release should not be viewed as alternatives or substitutes for the Company's reported GAAP results. A reconciliation to the most directly comparable GAAP financial measure is set forth in the tables that accompany this release.

The Company believes that the non-GAAP financial measures presented in this press release are relevant and provide useful information to the Company's management, investors, and other interested parties about the Company's operating performance because the measures allow them to understand and compare the Company's actual and expected operating results during the prior, current and future periods in a more consistent manner. The non-GAAP measures presented in this press release may not be comparable to similarly titled measures used by other companies. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to financial measures calculated in accordance with GAAP.

Safe Harbor Statement

The financial results in this press release reflect preliminary, unaudited results, which are not final until the Company’s Form 10-Q is filed with the Securities and Exchange Commission (“SEC�). This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,� “anticipates,� "assumes," “believes,� “estimates,� “expects,� “forecasts,� “future,� “intends,� “likely,� “may,� “outlook,� “plans,� “potential,� “projects,� “seeks,� “strategy,� “targets,� “trends,� “will,� “would,� “could,� “should,� and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things: our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full-year guidance for 2025. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.

Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.

Contact:
Robert Borchert
SVP, Investor & Corporate Communications
[email protected]
817.783.4841


Privia Health Group, Inc.
Condensed Consolidated Statements of Operations(g)
(unaudited)
(in thousands, except share and per share data)
For the Three Months Ended March 31,
20252024
Revenue$480,097$415,243
Operating expenses:
Provider expense374,809320,336
Cost of platform59,52654,057
Sales and marketing6,9226,085
General and administrative31,72132,121
Depreciation and amortization1,9011,821
Total operating expenses474,879414,420
Operating income5,218823
Interest income, net2,9312,984
Income before provision for income taxes8,1493,807
Provision for income taxes2,103751
Net income6,0463,056
Less: Net income attributable to non-controlling interests1,82672
Net income attributable to Privia Health Group, Inc.$4,220$2,984
Net income per share attributable to Privia Health Group, Inc. stockholders � basic$0.03$0.03
Net income per share attributable to Privia Health Group, Inc. stockholders � diluted$0.03$0.02
Weighted average common shares outstanding � basic120,623,670118,505,320
Weighted average common shares outstanding � diluted127,752,527125,053,404

(g) Any slight variations in totals due to rounding.

Privia Health Group, Inc.
Condensed Consolidated Balance Sheets(h)
(in thousands)
March 31, 2025December 31, 2024
Assets(unaudited)
Current assets:
Cash and cash equivalents$469,331$491,149
Accounts receivable388,727316,179
Prepaid expenses and other current assets28,40927,495
Total current assets886,467834,823
Non-current assets:
Property and equipment, net1,0141,242
Operating right-of-use asset4,7194,828
Intangible assets, net108,134109,807
Goodwill141,615141,615
Deferred tax asset24,67026,383
Other non-current assets16,91917,085
Total non-current assets297,071300,960
Total assets$1,183,538$1,135,783
Liabilities and stockholders� equity
Current liabilities:
Accounts payable and accrued expenses$68,136$81,986
Provider liability400,288364,607
Operating lease liabilities, current2,3862,553
Total current liabilities470,810449,146
Non-current liabilities:
Operating lease liabilities, non-current3,0493,037
Other non-current liabilities153153
Total non-current liabilities3,2023,190
Total liabilities474,012452,336
Commitments and contingencies
Stockholders� equity:
Common stock1,2141,203
Additional paid-in capital833,231813,209
Accumulated deficit(175,009)(179,229)
Total Privia Health Group, Inc. stockholders� equity659,436635,183
Non-controlling interest50,09048,264
Total stockholders� equity709,526683,447
Total liabilities and stockholders� equity$1,183,538$1,135,783

(h) Any slight variations in totals are due to rounding.

Privia Health Group, Inc.
Condensed Consolidated Statements of Cash Flows(i)
(unaudited)
(in thousands)
For the Three Months Ended March 31,
20252024
Cashflowsfromoperatingactivities
Net income$6,046$3,056
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation228294
Amortization of intangibles1,6731,527
Stock-based compensation17,79011,904
Deferred tax expense1,713863
Changes in asset and liabilities:
Accounts receivable(72,548)(55,320)
Prepaid expenses and other current assets(914)(10,391)
Other non-current assets and right-of-use asset275(1,321)
Accounts payable and accrued expenses(13,850)(7,180)
Provider liability35,68124,208
Operating lease liabilities(155)(777)
Net cash used in operating activities(24,061)(33,137)
Cash from investing activities
Business acquisitions, net of cash acquired(707)
Other(5,006)
Net cash used in investing activities(5,713)
Cash flows from financing activities
Proceeds from exercised stock options2,243475
Net cash provided by financing activities2,243475
Net decrease in cash and cash equivalents(21,818)(38,375)
Cash and cash equivalents at beginning of period491,149389,511
Cash and cash equivalents at end of period$469,331$351,136
Supplemental disclosure of cash flow information:
Interest paid$$93
Income tax refunds received$(313)$(230)

(i) Any slight variations in totals are due to rounding.

Additional Financial Information

Revenues disaggregated by source:

For the Three Months Ended March 31,
(DollarsinThousands)20252024
FFS-patient care$311,761$274,823
FFS-administrative services32,25529,076
Capitated revenue70,69051,304
Shared savings47,91247,464
Care management fees (PMPM)15,20110,603
Other revenue2,2781,973
Total Revenue$480,097$415,243

The Company’s liabilities for unpaid medical claims under at-risk capitation arrangements:

March 31,
(DollarsinThousands)20252024
Balance, beginning of period$66,355$67,138
Incurred health care costs:
Current year70,56551,040
Prior years(954)600
Total claims incurred$69,611$51,640
Claims paid:
Current year(10,273)(2,072)
Prior year(39,332)(42,185)
Total claims paid$(49,605)$(44,257)
Balance, end of period$86,361$74,521

Key Metrics and Non-GAAP Financial Measures

Privia Health reviews a number of operating and financial metrics, including the following key metrics and non-GAAP financial measures, to evaluate the Company’s business, measure performance, identify trends affecting the Company’s business, formulate business plans, and make strategic decisions.

Key Metrics(j)

For the Three Months Ended March 31,
(unaudited; $ in millions)20252024
Implemented Providers (as of end of period)(1)4,8714,359
Attributed Lives (as of end of period)(2)1,270,0001,143,000
Practice Collections(3)$798.6$707.7
(1)Implemented Providers is defined as the total of all service professionals on Privia Health’s platform at the end of a given period who are credentialed by Privia Health and billed for medical services, in both Owned and Non-Owned Medical Groups during that period.
(2)Attributed Lives are defined as any patient that a payer deems attributed to Privia to deliver care as part of a value-based care arrangement through a provider of primary care services as of the end of a particular period.
(3)Practice Collections are defined as the total collections from all practices in all markets and all sources of reimbursement that the Company receives for delivering care and providing Privia Health’s platform and associated services. Practice Collections differ from revenue by including collections from Non-Owned Medical Groups.
(j)Any slight variations in totals are due to rounding.

Non-GAAP Financial Measures (4)(k)

For the Three Months Ended March 31,
(unaudited; $ in thousands)20252024
Care Margin$105,288$94,907
Platform Contribution$51,733$44,737
Platform Contribution Margin49.1%47.1%
Adjusted EBITDA$26,915$19,922
Adjusted EBITDA Margin25.6%21.0%
(4)In addition to results reported in accordance with GAAP, Privia Health discloses Care Margin, Platform Contribution, Platform Contribution margin, Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures. Each are defined as follows:
  • Care Margin is Gross Profit excluding amortization of intangible assets.
  • Platform Contribution is Gross Profit, excluding amortization of intangible assets, less Cost of platform and excluding stock-based compensation expense included in Cost of platform.
  • Platform Contribution margin is Platform Contribution divided by Care Margin.
  • Adjusted EBITDA is net income attributable to Privia Health Group, Inc. shareholders and subsidiaries excluding non-controlling interests, provision for income taxes, interest income, interest expense, depreciation and amortization, stock-based compensation, employer taxes on equity vesting/exercises, severance charges and other non-recurring expenses.
  • Adjusted EBITDA Margin is Adjusted EBITDA divided by Care Margin.
(k)Any slight variations in totals are due to rounding.

Reconciliation of Gross Profit to Care Margin(l)

For the Three Months Ended March 31,
(unaudited; $ in thousands)20252024
Revenue$480,097$415,243
Provider expense(374,809)(320,336)
Amortization of intangible assets(1,673)(1,527)
Gross Profit$103,615$93,380
Amortization of intangibles assets1,6731,527
Care margin$105,288$94,907
(l)Any slight variations in totals are due to rounding.

Reconciliation of Gross Profit to Platform Contribution(m)

For the Three Months Ended March 31,
(unaudited; $ in thousands)20252024
Revenue$480,097$415,243
Provider expense(374,809)(320,336)
Amortization of intangibles assets(1,673)(1,527)
Gross Profit$103,615$93,380
Amortization of intangibles assets1,6731,527
Cost of platform(59,526)(54,057)
Stock-based compensation(5)5,9713,887
Platform Contribution$51,733$44,737
(m)Any slight variations in totals are due to rounding.
(5)Amount represents stock-based compensation expense included in Cost of Platform.

Reconciliation of Net Income to Adjusted EBITDA(n)

For the Three Months Ended March 31,
(unaudited; $inthousands)20252024
Net income$4,220$2,984
Net income attributable to non-controlling interests1,82672
Provision for income taxes2,103751
Interest income, net(2,931)(2,984)
Depreciation and amortization1,9011,821
Stock-based compensation17,79011,904
Other expenses(6)2,0065,374
Adjusted EBITDA$26,915$19,922
(n)Any slight variations in totals are due to rounding.
(6)Other expenses include employer taxes on equity vesting/exercises, severance and certain non-recurring costs.

Reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share(o)

For the Three Months Ended March 31,
(unaudited; $inthousands)20252024
Net income$4,220$2,984
Stock-based compensation17,79011,904
Intangible amortization expense1,6731,527
Provision for income tax2,103751
Other expenses(7)2,0065,374
Adjusted net income$27,792$22,540
Adjusted net income per share attributable to Privia Health Group, Inc. stockholders � basic$0.23$0.19
Adjusted net income per share attributable to Privia Health Group, Inc. stockholders � diluted$0.22$0.18
Weighted average common shares outstanding � basic120,623,670118,505,320
Weighted average common shares outstanding � diluted127,752,527125,053,404
(o)Any slight variations in totals due to rounding.
(7)Other expenses include employer taxes on equity vesting/exercises, severance and certain non-recurring costs.

FAQ

What were Privia Health's (PRVA) key financial results for Q1 2025?

Privia Health reported Q1 2025 revenue of $480.1M (+15.6% YoY), operating income of $5.2M (+534%), and net income of $4.2M (+41.4%). Practice Collections grew 12.8% to $798.6M, while Adjusted EBITDA increased 35.1% to $26.9M.

How is Privia Health (PRVA) expanding into Arizona?

Privia Health is entering Arizona through a $95M cash acquisition of Integrated Medical Services (IMS), adding approximately 70 physicians and providers across 21 locations. IMS will be implemented on the Privia Platform in Q4 2025.

What is Privia Health's (PRVA) updated guidance for 2025?

Privia Health raised its FY2025 guidance to the mid-to-high end of ranges, including Practice Collections of $3,150M-$3,250M, GAAP Revenue of $1,800M-$1,900M, and Adjusted EBITDA of $105M-$110M.

How many implemented providers and attributed lives does Privia Health (PRVA) have in Q1 2025?

As of Q1 2025, Privia Health had 4,871 implemented providers (+11.7% YoY) and 1,270,000 value-based care attributed lives (+11.1% YoY).

What is Privia Health's (PRVA) expected free cash flow conversion rate for 2025?

Privia Health expects at least 80% of Adjusted EBITDA to convert to free cash flow in full-year 2025.
Privia Health Group, Inc.

NASDAQ:PRVA

PRVA Rankings

PRVA Latest News

PRVA Latest SEC Filings

PRVA Stock Data

2.63B
114.04M
7.08%
97.07%
2.65%
Health Information Services
Services-health Services
United States
ARLINGTON